# Effects of 100 IU versus 150 IU hCG supplementation on oocyte and embryo quality in patients aged ≥ 35 years: a propensity score-matched analysis

**Authors:** Nguyen Thi Lien Huong, Tran Thu Thuy, Phi Thi Tu Anh, Hoang Bao Long, Le Duc Thang, Vu Thi Ngoc, Le Quang Do, Nguyen Xuan Anh Duy, Bui Thi Hanh, Do Van Loi, Le Hoang

PMC · DOI: 10.7150/ijms.106965 · International Journal of Medical Sciences · 2025-01-27

## TL;DR

This study compares two hCG doses in women over 35 undergoing IVF, finding that a higher dose increases total oocytes but not embryo quality.

## Contribution

A propensity score-matched analysis reveals that 150 IU hCG increases total oocyte yield in older IVF patients without compromising safety.

## Key findings

- 150 IU hCG resulted in significantly more total oocytes compared to 100 IU.
- No significant difference in mature oocyte numbers or embryo development between the two doses.
- Only one case of moderate ovarian hyperstimulation occurred in the 150 IU group.

## Abstract

Background: The optimal dose of human chorionic gonadotropin (hCG) supplementation during controlled ovarian stimulation (COS) remains controversial, particularly in women of advanced reproductive age.

Objective: To compare the efficacy and safety of 150 IU versus 100 IU daily hCG supplementation from stimulation day 6 in women aged ≥ 35 years undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI).

Methods: In this retrospective cohort study, we analyzed data from 438 patients aged ≥ 35 years undergoing IVF at a single center. Propensity score matching was performed at a 1:1 ratio, yielding 192 patients per group who received either 100 IU or 150 IU daily hCG supplementation from stimulation day 6 during GnRH antagonist cycles.

Results: After propensity score matching, baseline characteristics were comparable between groups. The 150 IU group yielded significantly more total oocytes (9.23±6.60 vs 7.79±5.52, p<0.001). However, the number of mature oocytes (6.25±5.12 vs 5.66±4.58) and day 3 embryos (5.22±4.62 vs 4.80±3.96) did not differ significantly between groups. Total FSH dose was similar (2664.84±141.91 vs 2666.02±142.51 IU, p=0.936). Only one case of moderate ovarian hyperstimulation syndrome occurred in the 150 IU group.

Conclusions: In women aged ≥ 35 years, while 150 IU daily hCG supplementation from stimulation day 6 safely increased total oocyte yield compared to 100 IU, it did not significantly improve mature oocyte numbers or embryo development.

## Linked entities

- **Proteins:** CGA (glycoprotein hormones, alpha polypeptide)

## Full-text entities

- **Diseases:** IVF (MESH:C537182), ovarian hyperstimulation syndrome (MESH:D016471)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11843143/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11843143/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC11843143/full.md

---
Source: https://tomesphere.com/paper/PMC11843143